EHC and EUPATI Partner to Advance Patient Education and Engagement in Therapeutic Innovation
The European Haemophilia Consortium (EHC) recently shared an announcement post on X:
”EHC has partnered with The European Patients’ Academy on Therapeutic Innovation to enhance education and research for European Patients. Together, we’ll strengthen the voice of the rare Bleeding Disorders community & improve outcomes across Europe.”
To read more, follow the link.
European Haemophilia Consortium has announced a new partnership with the European Patients’ Academy of Therapeutic Innovation (EUPATI), a nonprofit foundation dedicated to educating patients and the public on the medicine development process.
Representing over 120,000 individuals with rare bleeding disorders, the Consortium brings deep patient insight and multi-stakeholder collaboration to the alliance.
This partnership reflects both organizations’ shared commitment to empowering patients and strengthening the role of informed, engaged communities in shaping the future of healthcare.
Learn about the latest major collaborations in the field of Rare Diseases with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning